Evidence map›Paper›PMID 27708644›Full record

ArticleFrontiers in immunology2016

Comparative Analysis of Immune Activation Markers of CD8

Jinbiao Liu, Qianhao Xiao, Runhong Zhou, Yong Wang, Qiaoyang Xian, Tongcui Ma, Ke Zhuang, Li Zhou, Deyin Guo, Xu Wang and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. SIV Infection FacilitatesFrontiers in microbiology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Jinbiao LiuAnimal Biosafety Level III Laboratory, Center for Animal Experiment, Wuhan University School of Basic Medical Sciences , Wuhan , China.
Qianhao XiaoAnimal Biosafety Level III Laboratory, Center for Animal Experiment, Wuhan University School of Basic Medical Sciences , Wuhan , China.
Runhong ZhouAnimal Biosafety Level III Laboratory, Center for Animal Experiment, Wuhan University School of Basic Medical Sciences , Wuhan , China.
Yong WangAnimal Biosafety Level III Laboratory, Center for Animal Experiment, Wuhan University School of Basic Medical Sciences , Wuhan , China.
Qiaoyang XianAnimal Biosafety Level III Laboratory, Center for Animal Experiment, Wuhan University School of Basic Medical Sciences , Wuhan , China.
Tongcui MaAnimal Biosafety Level III Laboratory, Center for Animal Experiment, Wuhan University School of Basic Medical Sciences , Wuhan , China.
Ke ZhuangAnimal Biosafety Level III Laboratory, Center for Animal Experiment, Wuhan University School of Basic Medical Sciences , Wuhan , China.
Li ZhouAnimal Biosafety Level III Laboratory, Center for Animal Experiment, Wuhan University School of Basic Medical Sciences , Wuhan , China.
Deyin GuoDepartment of Pathology and Laboratory Medicine, Temple University Lewis Katz School of Medicine , Philadelphia, PA , USA.
Xu WangDepartment of Pathology and Laboratory Medicine, Temple University Lewis Katz School of Medicine , Philadelphia, PA , USA.
Wen-Zhe HoAnimal Biosafety Level III Laboratory, Center for Animal Experiment, Wuhan University School of Basic Medical Sciences, Wuhan, China; Department of Pathology and Laboratory Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.
Jieliang LiDepartment of Pathology and Laboratory Medicine, Temple University Lewis Katz School of Medicine , Philadelphia, PA , USA.
Wuhan University · CNTemple University · US

Funding

Opioids, HIV/HCV and Host Cell Innate ImmunityR01DA022177 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI HO, WENZHE · 2007 to 2017
$2.9M
Methamphetamine, Innate Immunity and HIVR01DA041302 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI HO, WENZHE · 2016 to 2020
$1.8M
Exosome in Methamphetamine and HIV-associated NeurodegenerationR21DA040329 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI LI, JIELIANG · 2015 to 2016
$427k
Methamphetamine, Brain Endothelial TLR3 Signaling and HIVR03DA036413 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI LI, JIELIANG · 2014 to 2015
$155k
NIDA NIH HHS R01 DA022177NIDA NIH HHS R01 DA041302NIDA NIH HHS R03 DA036413NIDA NIH HHS R21 DA040329
6 · The paper itself

Abstract

Altered T-cell homeostasis, such as expansion of CD8

Indexed as

CD4/CD8 ratioCD8 activationimmune activationlymph nodessimian immunodeficiency virus

Identifiers

PMID27708644
PMCPMC5030343
OpenAlexW2522586897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.